Search

Search Constraints

You searched for: Author/Creator Taylor, Thomas

Search Results

2. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020)

3. 319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine. (9th November 2020)

8. Adverse Event Triggered Event Reporting for Devices: Report of a Food and Drug Administration–Supported Feasibility Pilot of Automated Adverse Event Reporting. Issue 2 (April 2016)

10. ATIM-28. PHASE II TRIAL OF AV-GBM-1 (AUTOLOGOUS DENDRITIC CELLS LOADED WITH TUMOR ASSOCIATED ANTIGENS) AS ADJUNCTIVE THERAPY FOLLOWING SURGERY PLUS CONCURRENT CHEMORADIATION IN NEWLY DIAGNOSED GBM PATIENTS. (11th November 2019)